LYNE SCHAEFER ALFONSE: Open Payments
NPI 1619907110 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,873 in 115 payments from 19 companies in 2025. Trend: 2023 $7,991 · 2024 $3,016 · 2025 $2,873
Food & beverage: $2,873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $879 |
| Janssen Biotech, Inc. | 13 | $397 |
| Novartis Pharmaceuticals Corporation | 17 | $304 |
| Amgen Inc. | 12 | $264 |
| AstraZeneca Pharmaceuticals LP | 6 | $234 |
| GENZYME CORPORATION | 5 | $165 |
| UCB, Inc. | 4 | $104 |
| Organon LLC | 4 | $93 |
| SOBI, INC | 2 | $60 |
| Lilly USA, LLC | 2 | $57 |
Products named: RINVOQ, TREMFYA, COSENTYX, SAPHNELO, SKYRIZI, KEVZARA, TAVNEOS, Bimzelx.
Industry payments across WA — which companies pay providers there.
